A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 productionNAIR, A. P. K; DIAMANTIS, I. D; CONSCIENCE, J.-F et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 3, pp 1183-1190, issn 0270-7306, 8 p.Article

Regulation of a collagen gene promoter by the product of viral mos oncogeneSCHMIDT, A; SETOYAMA, C; DE CROMBRUGGHE, B et al.Nature (London). 1985, Vol 314, Num 6008, pp 286-289, issn 0028-0836Article

Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinaseSIU-POK YEE; MOCK, D; GREER, P et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 12, pp 5491-5499, issn 0270-7306, 9 p.Article

Pleiotropic Action of AP-1 in v-Src-Transformed CellsLIZHEN WANG; RODRIGUES, Natalie A; YING WU et al.Journal of virology. 2011, Vol 85, Num 13, pp 6725-6735, issn 0022-538X, 11 p.Article

Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc conditional regulation of c-myc transcription by temperature-sensitive v-ablCLEVELAND, J. L; DEAN, M; ROSENBERG, N et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 12, pp 5685-5695, issn 0270-7306, 11 p.Article

OncogenesCOLB, M; KRONTIRIS, T. G.Advances in internal medicine. 1986, Vol 31, pp 47-70, issn 0065-2822Article

Constitutive phosphorylation of a Rac GAP MgcRacGAP is implicated in v-Src-induced transformation of NIH3T3 cellsDOKI, Noriko; KAWASHIMA, Toshiyuki; NOMURA, Yasushi et al.Cancer science. 2009, Vol 100, Num 9, pp 1675-1679, issn 1347-9032, 5 p.Article

Oncogenes and human cancerPIMENTEL, E.Cancer genetics and cytogenetics. 1985, Vol 14, Num 3-4, pp 347-368, issn 0165-4608Article

Oncogènes viraux et cellulaires. I: généralités = Viral and cellular oncogenes. I. ReviewBISERTE, G.LARC médical. 1985, Vol 5, Num 9, pp 477-484, issn 0242-9462Article

Increased Bcl-x_L expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cellsLOZA COLL, Mariano; ROSEN, Kirill; LADEDA, Virginia et al.Oncogene (Basingstoke). 2002, Vol 21, Num 18, pp 2908-2913, issn 0950-9232Article

Mechanisms of tumor induction by human retrovirusesFERDINAND, F.-J.Arzneimittel-Forschung. 1989, Vol 39, Num 6, pp 737-740, issn 0004-4172Article

Novel insights into c-Src : Anti-cancer drugsALPER, Ö; BOWDEN, E. T.Current pharmaceutical design. 2005, Vol 11, Num 9, pp 1119-1130, issn 1381-6128, 12 p.Article

Two-dimensional electrophoretic analysis of transformation-sensitive polypeptides during chemically, spontaneously, and oncogene-induced transformation of rat liver epithelial cellsWIRTH, P. J; LUO, L.-D; FUJIMOTO, Y et al.Electrophoresis (Weinheim. Print). 1992, Vol 13, Num 5, pp 305-320, issn 0173-0835Article

SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblastsTSUYAMA, N; MIURA, M; KITAHIRA, M et al.Cell structure and function. 1991, Vol 16, Num 1, pp 55-62, issn 0386-7196Article

Immortalization of primary cells by DNA tumor virusesLINDER, S; MARSHALL, H.Experimental cell research. 1990, Vol 191, Num 1, pp 1-7, issn 0014-4827, 7 p.Article

The emerging genetics of cancerSKINNER, M. A; IGLEHART, J. D.Surgery, gynecology & obstetrics. 1989, Vol 168, Num 4, pp 371-379, issn 0039-6087Article

Oncogenes from hormone receptorsPARKER, M. G.Journal of endocrinology. 1987, Vol 112, Num 1, pp 1-2, issn 0022-0795Article

Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene productWEINBERGER, C; HOLLENBERG, S. M; ROSENFELD, M. G et al.Nature (London). 1985, Vol 318, Num 6047, pp 670-672, issn 0028-0836Article

The avian sarcoma virus PRCII lacks 1020 nucleotides of the fps transforming gene = Le virus du sarcome PRC II est dépourvu de 1020 nculéotides du gène transformant fpsCARLBERG, K; CHAMBERLIN, M. E; BEEMON, K et al.Virology (New York, NY). 1984, Vol 135, Num 1, pp 157-167, issn 0042-6822Article

Nucleotide sequence of the transforming gene of m1 murine sarcoma virus = Séquence nucléotidique du gène transformant du virus du sarcome murin M1BROW, M. A. D; SEN, A; SUTCLIFFE, J. G et al.Journal of virology. 1984, Vol 49, Num 2, pp 579-582, issn 0022-538XArticle

The v-erbA oncogene blocks expression of α2/β1 integrin a normal inhibitor of erythroid progenitor proliferationMEY, Anne; GANDRILLON, Olivier; MCNAGNY, Kelly M et al.Oncogene (Basingstoke). 2002, Vol 21, Num 18, pp 2864-2872, issn 0950-9232Article

Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factorsCLARK, W; GILLESPIE, D. A. F.Cell growth and differentiation. 1997, Vol 8, Num 4, pp 371-380, issn 1044-9523Article

Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cellsDUMENIL, D; NEEL, H; LACOUT, C et al.Experimental hematology. 1994, Vol 22, Num 2, pp 178-185, issn 0301-472XArticle

The discovery of ras and its biological importanceWEINBERG, R. A.Handbook of experimental pharmacology. 1993, Vol 108, pp 249-258, issn 0171-2004, 1Article

Adenovirus E1a as a tumor-suppressor geneCHINNADURAI, G.Oncogene (Basingstoke). 1992, Vol 7, Num 7, pp 1255-1258, issn 0950-9232Article